LAB - Standard BioTools Inc. -  [ ]

Ticker Details
Standard BioTools Inc.
IPO Date: March 1, 2011
Sector: Healthcare
Industry: Diagnostics and Research
Market Cap: $434.56M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.07 | 3.50%
Avg Daily Range (30 D): $0.04 | 2.63%
Avg Daily Range (90 D): $0.04 | 2.97%
Institutional Daily Volume
Avg Daily Volume: .31M
Avg Daily Volume (30 D): 1.16M
Avg Daily Volume (90 D): 1.47M
Trade Size
Avg Trade Size (Sh.): 195
Avg Trade Size (Sh.) (30 D): 214
Avg Trade Size (Sh.) (90 D): 224
Institutional Trades
Total Institutional Trades: 123
Avg Institutional Trade: $1.86M
Avg Institutional Trade (30 D): $1.02M
Avg Institutional Trade (90 D): $3.28M
Avg Institutional Trade Volume: .99M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $2.87M
Avg Closing Trade (30 D): $1.02M
Avg Closing Trade (90 D): $.78M
Avg Closing Volume: 1.54M
 
News
Feb 10, 2026 @ 12:00 PM
Standard BioTools to Announce Fourth Quarter and F...
Source: Na
Jul 21, 2025 @ 11:00 AM
Standard BioTools Schedules Second Quarter Earning...
Source: Marissa Bychir
Apr 22, 2025 @ 11:00 AM
Standard BioTools Schedules First Quarter Earnings...
Source: N/A
Jan 13, 2025 @ 12:00 PM
Standard BioTools Announces Preliminary Fourth Qua...
Source: N/A
Dec 19, 2024 @ 1:00 PM
Standard BioTools to Present at the 43rd Annual J....
Source: N/A
Financials
  TTM Q3 2025 Q2 2025
Basic EPS $-.33 $-.09 $-.09
Diluted EPS $-.33 $-.09 $-.09
Revenue $169.74M $19.55M $21.76M
Gross Profit $81.9M $9.48M $10.63M
Net Income / Loss $-128.25M $-34.69M $-33.46M
Operating Income / Loss $-159.44M $-32.94M $-25.7M
Cost of Revenue $87.84M $10.07M $11.13M
Net Cash Flow $-79.93M $-29.2M $7.73M
PE Ratio